📰 **Why This Biotech Fund Increased Its Oruka Therapeutics Stake Amid a Staggering 500% Rally**

Key PointsAvidity Partners added 100,000 shares of Oruka Therapeutics in the first quarter; the estimated trade size was $3.48 million.

🔗 https://www.nasdaq.com/articles/why-biotech-fund-increased-its-oruka-therapeutics-stake-amid-staggering-500-rally

#markets #news